AIRS Medical Inc. receives MDSAP Certification, Paving the Way for Global Expansion

SEOUL, South Korea, Sept. 13, 2023 /PRNewswire/ — AIRS Medical Inc., an AI-powered healthcare solution provider headquartered in Korea announces the attainment of MDSAP (Medical Device Single Audit Program) certification. This milestone achievement underscores AIRS Medical’s commitment to quality excellence on a global scale, further propelling the company’s flagship product, SwiftMR™, towards an accelerated trajectory of international expansion.

MDSAP certification confirms the comprehensive achievement of regulatory audit requirements and compliance standards for medical device manufacturers looking to sell products within the United States (FDA), Canada (HC), Japan (MHLW), Australia (TGA), and Brazil (ANVISA).

The MDSAP certification stands as a testament to AIRS Medical’s adherence to top-tier quality management practices. This endorsement signifies that AIRS Medical’s quality management system has met the exacting standards set forth by the MDSAP regulatory framework.

One of the key advantages of the MDSAP certification lies in its potential to expedite product approvals and market access. By streamlining the regulatory processes across multiple jurisdictions, AIRS Medical Inc. can now navigate the complex landscape of global markets with heightened efficiency. This acceleration in regulatory clearance is expected to facilitate the international expansion of SwiftMR™, the company’s renowned AI-powered MRI enhancement solution.

“At AIRS Medical, we’ve always been driven by a commitment to excellence and innovation,” says Hyeseong Lee, CEO of AIRS Medical. “The MDSAP certification reinforces our commitment to providing the highest quality of care through the digital transformation of the healthcare experience.”

SwiftMR™ has already garnered widespread recognition for its ability to reduce the scan time and enhance image quality through Deep-learning technology. With the newly acquired MDSAP certification, SwiftMR™ is poised to extend its positive impact across borders, ensuring patients and healthcare providers around the world can benefit from its capabilities.

 

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.